Improved infield response rates and overall survival in patients with metastatic melanoma receiving higher biological equivalent doses of radiation with ipilimumab-Reference-Cited by-同舟云学术

Improved infield response rates and overall survival in patients with metastatic melanoma receiving higher biological equivalent doses of radiation with ipilimumab

Published:2017-04-08 Issue:2 Volume:6 Page:215-223
ISSN:1948-7894
Container-title:Journal of Radiation Oncology
language:en
Short-container-title:J Radiat Oncol

Author:

Mackley Heath B.,Liu Jason,Zhu Junjia,Wagner Henry,Talamo Giampaolo,Schell Todd D.,Pameijer Colette,Neves Rogerio I.,Anderson Bryan,Kokolus Kathleen M.,Sivik Jeffrey,Mallon Carol A.,Koller Kristian M.,Drabick Joseph J.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1007/s13566-017-0305-8/fulltext.html

Reference31 articles.

1. Ferri F. Melanoma. In: Ferri’s Clinical Adviser. 2nd ed.; 2017:773–775. doi: 10.1016/B978-0-12-382176-8.00001-6 .

2. Gangadhar TC, Fecher LA, Miller CJ, et al. Melanoma. Abeloff’s Clin Oncol. 2014:1071–1091.e3. doi: 10.1016/B978-1-4557-2865-7.00069-2 .

3. Miller AJ, Mihm MC (2006) Melanoma. N Engl J Med 355(1):51–65. doi: 10.1056/NEJMra052166

4. Chandra RA, Wilhite TJ, Balboni TA et al (2015) A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology. 4(11):e1046028. doi: 10.1080/2162402X.2015.1046028

5. Grimaldi AM, Simeone E, Giannarelli D et al (2014) Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Oncoimmunology 3:e28780. doi: 10.4161/onci.28780

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying the Optimal Fractionation Schedules for Improved Response Rates and Survival in Patients with Metastatic Melanoma Treated with Ipilimumab and Radiotherapy;Current Cancer Therapy Reviews;2020-02-06

2. Combining immunotherapy with radiation therapy to induce the abscopal response: What clinical and treatment variables matter?;Applied Radiation Oncology;2019-03-01